Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-02

Clinical Trial Update: BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder [Phase 3]

View source ↗

Summary

BOSCOT is a Phase 3 randomized controlled trial evaluating cognitive behavioral therapy for Borderline Personality Disorder, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Aberdeen | Conditions: Borderline Personality Disorder | Phase 3 | Status: COMPLETED